MEDDESKTOP

NPI Registry, International Classification of Diseases,ICD,HCPCS, , CPT, National Drug Codes,NDC, SNOMED CT, MEDCIN, Medical news, Health news, Healthcare news, General welfare, and healthy living will bring forth a healthy society. This site is not intended to provide medical advice, diagnosis or treatment. Disclosure; This site shows ads compensated for them.

Showing posts with label caplacizumab-yhdp. Show all posts
Showing posts with label caplacizumab-yhdp. Show all posts
Wednesday, February 06, 2019

FDA Approves Cablivi (caplacizumab-yhdp) injection by Ablynx, a sanofi company, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP)

›
FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder The U.S. Food and Drug Administr...
›
Home
View web version

Contributors

  • OncoWikia
  • ravenII
  • sol@rion
Powered by Blogger.